MEI Pharma, Inc. Annual Return On Equity in % from 2012 to 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
MEI Pharma, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2024.
  • MEI Pharma, Inc. Return On Equity for the quarter ending June 30, 2024 was 31.6 %.
  • MEI Pharma, Inc. annual Return On Equity for 2024 was 31.6 %.
  • MEI Pharma, Inc. annual Return On Equity for 2023 was -88 %, a 7.13% increase from 2022.
  • MEI Pharma, Inc. annual Return On Equity for 2022 was -94.8 %, a 54.8% decline from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 31.6 +120 Jul 1, 2023 Jun 30, 2024
2023 -88 +6.76 +7.13% Jul 1, 2022 Jun 30, 2023
2022 -94.8 -33.5 -54.8% Jul 1, 2021 Jun 30, 2022
2021 -61.3 +7.08 +10.4% Jul 1, 2020 Jun 30, 2021
2020 -68.3 -30.8 -81.9% Jul 1, 2019 Jun 30, 2020
2019 -37.6 +59.4 +61.3% Jul 1, 2018 Jun 30, 2019
2018 -97 -102 -1943% Jul 1, 2017 Jun 30, 2018
2017 5.26 +47.8 Jul 1, 2016 Jun 30, 2017
2016 -42.6 +13.1 +23.5% Jul 1, 2015 Jun 30, 2016
2015 -55.6 +2.29 +3.96% Jul 1, 2014 Jun 30, 2015
2014 -57.9 -6.19 -12% Jul 1, 2013 Jun 30, 2014
2013 -51.7 +168 +76.5% Jul 1, 2012 Jun 30, 2013
2012 -220 Jul 1, 2011 Jun 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.